The global Endocrine Testing Market is presently valued at US$ 2536.7 million and is expected to grow at an 8.5% CAGR. With the increased prevalence of diabetes and the aging population, the market is expected to reach US$ 5735 million by 2032. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive...